RetmarkerAMD® validation: published in the Eye newspaper, a Springer Nature group and official publication of the UK College of Ophthalmologists.

We are pleased to announce our latest publication on RetmarkerAMD® validation, published in the Eye newspaper, a Springer Nature group and official publication of the UK College of Ophthalmologists.

By conducting a carefully planned multicentre, cross-sectional study, we were able to demonstrate that RetmarkerAMD® is a reliable and consistent semiautomated classification tool for Age-related Macular Degeneration, which may be used both in clinical studies and in clinical trials.

RetmarkerAMD® is a software developed by the Retmaker company in partnership with AIBILI that facilitates the marking and counting of Age-related Macular Degeneration (AMD) lesions. It was initially developed for the epidemiological Coimbra Eye Study and has since been used in several other studies.

Journal Reference:

https://www.nature.com/articles/s41433-019-0624-7